7-.1 Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse
W Shin, DH Lee, H Yoo, H Jung, M Bang, A Kim
Pharmaceuticals 17 (7), 882
7-2. Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISA
A Kim, MS Oh, GH Lee, S Song, M Byun, D Choi, BY Yu, H Lee
Antibody Therapeutics 7 (2), 105-113
7-3. A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference …
A Kim, JH Hong, W Shin, H Yoo, JG Jung, JY Reginster, SH Kim, YJ Bae, ...
Expert Opinion on Biological Therapy, 1-9
7-4. No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
W Shin, MY Park, J Kim, J Kim, JH Nam, J Choi, AY Yang, H Yoo, YS Lee, ...
Clinical and Translational Science 17 (1), e13701
7-5. Drug–Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly
W Shin, AY Yang, H Yoo, A Kim
Pharmaceuticals 16 (10), 1457
7-6. Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration
S Bae, KY Huh, J Oh, KS Yu, A Kim
Pharmaceuticals 16 (1), 132
7-7. Comparison of international guidelines for early-phase clinical trials of cellular and gene therapy products
W Shin, MG Kim, A Kim
Translational and Clinical Pharmacology 30 (1), 13
7-8. An Investigation of the Metabolism and Excretion of KD101 and Its Interindividual Differences: A Microtracing Mass Balance Study in Humans
A Kim, SR Dueker, JG Hwang, J Yoon, SW Lee, HS Lee, BY Yu, KS Yu, ...
Clinical and Translational Science 14 (1), 231-238
7-9. Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor‐Mediated Recycling of HL2351, a Novel Hybrid Fc‐Fused Interleukin‐1 Receptor Antagonist, to Optimize …
L Ngo, J Oh, A Kim, H Back, W Kang, J Chae, H Yun, H Lee
CPT: Pharmacometrics & Systems Pharmacology 9 (10), 584-595
7-10. Increasing prevalence and mortality of asthma with age in Korea, 2002–2015: a nationwide, population-based study
E Lee, A Kim, YM Ye, SE Choi, HS Park
Allergy, asthma & immunology research 12 (3), 467
7-11. Exposure-response and clinical outcome modeling of inhaled budesonide/formoterol combination in asthma patients
H Back, JB Lee, A Kim, SJ Park, J Kim, J Chae, SS Sheen, L Kagan, ...
Pharmaceutics 12 (4), 336
7-12. Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose
A Kim, SR Dueker, F Dong, AF Roffel, S Lee, H Lee
Bioanalysis 12 (2), 87-98
7-13. Evaluation of the Effect of CYP2D6 Genotypes on Tramadol and O-Desmethyltramadol Pharmacokinetic Profiles in a Korean Population Using Physiologically …
HC Jeong, SH Bae, JW Bae, S Lee, A Kim, Y Jang, KH Shin
Pharmaceutics 11 (11), 618
7-14. Trabecular bone score is more sensitive to asthma severity and glucocorticoid treatment than bone mineral density in asthmatics
YJ Choi, HY Lee, D Yoon, A Kim, YS Shin, HS Park, YM Ye
Allergy, Asthma & Immunology Research 11 (3), 343-356